0QLZ.LSE Bellevue Group AG
- Market cap
- GBP 112M
- P/E
- 2.1x
- P/B
- -
- ROE
- 6.1%
- Dividend yield
- 0.02%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0QLZ.LSE undervalued?
Graham numberThe Graham number of Bellevue Group AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bellevue Group AG fundamental analysis
No fundamental analysis for Bellevue Group AG yet.
Bellevue Group AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bellevue Group AG
Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid-caps, and private equity strategies; and multi asset and bond solutions. The company was founded in 1993 and is headquartered i…
Full company profileBellevue Group AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bellevue Group AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 74.5M | 102M | 94.2M | 102M | 110M | 142M | 99.4M | 81.9M | 72.0M | 53.0M | 105M |
| Gross Profit | 70.1M | 96.3M | 87.1M | 97.2M | 105M | 137M | 92.3M | 78.3M | 66.1M | 45.6M | 91.6M |
| Operating Income | 11.9M | 27.3M | 27.8M | 36.1M | 41.6M | 56.6M | 31.2M | 20.1M | 12.7M | 3.79M | 12.4M |
| EBITDA | 14.3M | 32.2M | 35.1M | 40.6M | 46.4M | 60.3M | 34.9M | 23.8M | 16.9M | 7.44M | 16.8M |
| Net Income | 12.3M | 28.7M | 29.7M | 36.3M | 41.6M | 56.5M | 31.2M | 15.2M | 9.16M | 1.89M | 7.08M |
| EPS | 0.92 | 17,958,125 | 19,963,087 | 2.59 | 3.10 | 4.25 | 2.35 | 1.15 | 0.69 | 0.14 | 0.53 |
| Balance Sheet | |||||||||||
| Total Assets | 464M | 462M | 467M | 393M | 236M | 227M | 185M | 156M | 162M | 156M | 151M |
| Total Liabilities | 305M | 285M | 270M | 195M | 69.7M | 80.0M | 51.3M | 33.1M | 43.8M | 38.6M | 34.3M |
| Shareholders' Equity | 159M | 177M | 197M | 198M | 166M | 147M | 134M | 122M | 119M | 117M | 117M |
| Cash & Short-term Investments | 123M | 127M | 144M | 128M | 129M | 130M | 100M | 82.3M | 72.6M | 65.3M | 63.6M |
| Total Debt | 16.2M | 6.15M | 561K | 7.21M | 4.25M | 2.55M | 3.29M | 3.47M | 19.2M | 32.0M | 16.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -13.5M | 83.5M | 34.7M | -17.4M | 149M | 69.7M | 28.2M | 8.89M | 9.40M | 19.3M | 20.3M |
| Capital Expenditure | 56.0K | 331K | 1.52M | 644K | 429K | 118K | 974K | 69.0K | 4.27M | 385K | 712K |
| Free Cash Flow | -13.6M | 83.1M | 33.2M | -18.1M | 148M | 69.6M | 27.2M | 8.82M | 5.14M | 18.9M | 19.6M |
| Ratios | |||||||||||
| ROE | 7.7% | 16.2% | 15.1% | 18.3% | 25.1% | 38.6% | 23.3% | 12.4% | 7.7% | 1.6% | 6.1% |
| ROA | 2.7% | 6.2% | 6.4% | 9.2% | 17.7% | 24.9% | 16.9% | 9.8% | 5.6% | 1.2% | 4.7% |
| Net Profit Margin | 16.5% | 28.0% | 31.6% | 35.6% | 37.7% | 39.8% | 31.4% | 18.6% | 12.7% | 3.6% | 6.7% |
| Debt to Equity | 0.10x | 0.03x | 0.00x | 0.04x | 0.03x | 0.02x | 0.02x | 0.03x | 0.16x | 0.27x | 0.14x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bellevue Group AG dividends
- Dividend yield
- 0.02%
- Forward dividend
- -
- Payout ratio
- 493.1%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 9.30M | 0.70 | 493.1% |
| 2024 | 15.1M | 1.14 | 165.3% |
| 2023 | 26.4M | 1.99 | 173.2% |
| 2022 | GBP 13.4M | 1.01 | 43.0% |
| 2021 | GBP 19.9M | 1.49 | 35.1% |
| 2020 | GBP 20.2M | 1.51 | 48.6% |
| 2019 | GBP 14.8M | 1.06 | 40.8% |
| 2018 | GBP 14.8M | 9,937,584 | 49.8% |
| 2017 | GBP 13.5M | 8,413,125 | 46.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 243:229 on Apr 12, 2016.
Who owns Bellevue Group AG
- Insiders 47.39%
- Institutions 4.94%
- Public & others 47.68%
- Shares outstanding 13.4M
- Free float 13.3M
Bellevue Group AG company profile
- Company name
- Bellevue Group AG
- Ticker
- 0QLZ.LSE
- Exchange
- London Exchange
- Sector
- Financial Services
- Industry
- Commercial Services & Supplies
- Employees
- 69
- Fiscal year end
- December
- Address
- Theaterstrasse 12, Zurich, Switzerland, 8001
- Phone
- 41 44 267 67 00
- Website
- bellevue.ch
About Bellevue Group AG
Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid-caps, and private equity strategies; and multi asset and bond solutions. The company was founded in 1993 and is headquartered in Zurich, Switzerland.
Bellevue Group AG management
4- Mr. Veit D. de MaddalenaExecutive Chairman · born 1967
- Mr. Markus PeterCEO of Bellevue Asset Management
- Mr. Stefano MontalbanoCRO, CFO & Member of Executive Board
- Mr. Patrick FischliHead Distribution